EN DE
Watch Cellularline for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Cellularline (CELL) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Cellularline stock €6.77, price €2.70, upside +150.7%, quality 54 out of 100. Rating: strongly undervalued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology IT · ISIN IT0005244618

C Cellularline logo Some data Nov 10, 2026

Cellularline

CELL · MI
Meets all rules

The stock costs 60% less than our calculation considers fair.

Fair value €6.77 · Strongly undervalued
Low debt
Generates free cash flow
4.0% dividend yield · Cash covered
Even on cautious assumptions the value is 72% above the price (€4.64).
Quality 54/100
Mixed Growth (revenue 5y +8.4 %/yr in EUR)
Mixed vs. peers (7/13)
Some data
Loss-making · -22.3% net margin (TTM)
Narrow moat 16/100 · thin data
Watch Cellularline for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€3.75 €1.83 Fair Value €6.77 Sep 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range €1.83 – €3.75 · fair‑value band €4.64 – €9.11 · the €2.70 price screens below the €6.77 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Cellularline in your weekly email

Every Wednesday you see whether Cellularline is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cellularline S.p.A. manufactures and sells accessories for smartphones and tablets.

Show moreShow less

It offers accessories for multimedia devices, including cases, covers, car holders, protective glasses, power supplies, portable chargers, charging cables, headphones, earphones, speakers, wearable technology products, and travel adapters; and products and accessories related to motorbikes and cycling, such as intercoms and smartphone supports.

The company provides its brands under the Cellularline, Ploos, AUDIO QUALITY LAB, MUSIC SOUND, NOVA E COSMO, INTERPHONE, SKROSS, Q2 POWER, COVERLAB, Newrban, and Peter Jäckel brand names.

It operates in Italy, Spain, Portugal, Eastern Europe, Germany, Northern Europe, France, Benelux, Switzerland, the Middle East, and internationally. The company was founded in 1990 and is headquartered in Reggio Emilia, Italy.

Stock analysis

Cellularline (CELL) currently trades at €2.70, while our model-based Fair Value estimate is €6.77, implying the stock looks roughly 60% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €8.96 per share, and 10 of the 11 models we run sit above the €2.70 price.

Bear case: the Asset-Based group reads lowest at €2.08, and 1 of the 11 models stay below the price. Data coverage for this calculation is medium.

Scenario range: €4.64 (bear) to €9.11 (bull), the price of €2.70 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Cellularline reported revenue of €157M in FY2025 versus €111M in FY2021, a compound +9.1%/yr. Reported net income was −€36.3M in FY2025.

Key figures

Market cap €56.1M Micro · P/S ratio 0.37 · EPS (TTM) €−1.65 · Dividend yield 4.0% · Net margin −22.3% · Return on equity −30.8% · Return on assets (EBIT) −10.0% (5-year average) · Operating margin 1.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 16 out of 100 (low confidence).

What moves the price

The share trades about 4% below its 52-week high and 33% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at −14% fair-value upside, at 151%, CELL screens cheaper than that median.

Fair Value models

Bear €4.64 Fair Value €6.77 Bull €9.11
Price €2.70 · Upside +150.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF €4.44 €5.77 €7.23 82
Growth DCF €4.49 €5.70 €6.97 80
Owner Earnings €5.04 €6.52 €8.15 78
All 11 models by family
DCF Models
FCF DCF €4.44 €5.77 €7.23 82
Owner Earnings €5.04 €6.52 €8.15 78
5Y Revenue Exit €4.64 €7.01 €9.86 73
5Y EBITDA Exit €5.24 €8.06 €11.15 75
10Y Revenue Exit €4.38 €6.19 €8.35 67
10Y EBITDA Exit €4.80 €6.77 €9.11 69
Multiples
EV/EBITDA €7.29 €9.84 €12.39 67
EV/Revenue €5.54 €8.08 €10.61 53
Asset-Based
NCAV (Graham) €1.37 €2.08 €2.60 54
Growth DCF
Growth DCF €4.49 €5.70 €6.97 80
Rev-Margin DCF €4.64 €7.10 €9.70 73

Open the full fair value analysis →

Quality Score breakdown

Overall quality 54/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 26
How much profit the company makes from its sales and capital
Quality Growth 41
Are margins and returns getting better?
Cashflow 52
Do the profits arrive as real cash?
Financial strength 50
Debt, balance sheet and risk of trouble
Investment 97
Does it invest with discipline instead of growing at any price?
Low Volatility 90
How calm the share price moves, does not count
Price momentum 61
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 67
Distance to the 52-week high, does not count
New shares 85
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 48/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−4.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.4%
Start year 2020 (pandemic). Over 10 years: +0.0% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+267.3%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.0% (2020) → −24.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−11.0%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −12.9% a year for the price.

Watch CELL, get fair value alerts →

Compare Cellularline with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Consumer Electronics · 115 stocks

Beats the industry median on 7/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 54 · Above median
Fair Value upside +150.7% · Top 25%
Profitability
Return on assets −20.9% · Bottom 25%
Net margin (12 months) −22.3% · Bottom 25%
Operating margin (12 months) 1.6% · Below median
Growth and dividend
Revenue growth (quarter YoY) 0.1% · Below median
Dividend yield (12 months) 4.0% · Above median
Balance sheet
Debt / equity 0.15× · Above median

Valuation Multiplesvs Consumer Electronics median · lower = cheaper

P/B 0.58× · Cheapest 25%
P/S (12 months) 0.36× · Cheapest 25%
Price / free cash flow (fiscal year) 4.1× · Cheapest 25%
EV/EBITDA 5.2× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 12
FUTURE (revenue growth)1 · sector 27
PAST (return on equity)0 · sector 22
HEALTH (low debt)93 · sector 96
DIVIDEND (yield)80 · sector 34

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Consumer Electronics stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Xiaomi Corporation 1810 HK$30.10 HK$44.93 +49% vs CELL
Sony Group SONY $27.06 $29.40 +9% vs CELL
LG Electronics Inc 066570 134,700 KRW 146,023 KRW +8% vs CELL
Huaqin Co 603296 ¥66.43 ¥68.54 +3% vs CELL
Shenzhen Transsion Holdings 688036 ¥62.94 ¥54.13 −14% vs CELL
Samsung Electronics Co 005930 189,900 KRW 162,261 KRW −15% vs CELL
Anker Innovations Limited 300866 ¥109.82 ¥77.69 −29% vs CELL
LG Corp 003550 89,700 KRW 62,954 KRW −30% vs CELL
Goertek Inc 002241 ¥24.74 ¥14.64 −41% vs CELL
Sharetronic Data Technology Co 300857 ¥149.21 ¥30.19 −80% vs CELL

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cellularline: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Cellularline Fair Value". https://www.fairvalue-calculator.com/stock/CELL

Frequently asked questions

Is Cellularline (CELL) overvalued or undervalued?
As of Nov 10, 2026, our model estimates a fair value of €6.77 versus a price of €2.70, about +151% upside (undervalued).
What is the fair value of CELL?
Our model-based fair value for Cellularline is €6.77 (as of Nov 10, 2026), built from audited fundamentals. The current price: €2.70.
What is the quality score of CELL?
Cellularline has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cellularline (CELL)?
Our model-based price target is the fair value of €6.77 (as of Nov 10, 2026) from 11 valuation models. Cautious scenario €4.64, optimistic scenario €9.11. It is a calculation from audited fundamentals, not an analyst target.
What is the Cellularline stock forecast for 2026?
Our models put fair value at €6.77, about +151% upside versus a price of €2.70 (undervalued). Cautious scenario €4.64, optimistic scenario €9.11. The calculation is refreshed regularly with new filings.
What is the revenue of Cellularline (CELL)?
Cellularline reported trailing-twelve-month revenue of about €157M (latest available figure, as of Nov 10, 2026).
Does Cellularline pay a dividend?
Cellularline currently shows a dividend yield of 4.00% relative to its recent price (as of Nov 10, 2026).
How much is the dividend of Cellularline (CELL) and when is the ex-dividend date?
Cellularline pays a dividend of €0.108 per share a year, a dividend yield of 4.0%. The last ex-dividend date was May 18, 2026. Free cash flow covers the dividend 6.02 times. Our assessment: Cash covered. The dividend is fully funded by free cash flow. The payout ratio on earnings is not available for this company.
What growth is priced into Cellularline (CELL)?
For today's price to be fair in a discounted-cash-flow model, Cellularline would have to grow free cash flow by -11.0 % per year for five years (discount rate 13.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.4 % per year. As of Nov 10, 2026.
What discount rate (WACC) does the fair value of CELL use?
Our models discount Cellularline at 13.5 %: a base by market capitalisation (micro), damped by beta 0.34, country premium for Italy. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cellularline that is -11.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.5 %) and the same formula as our fair value.
How much growth has Cellularline (CELL) delivered so far?
Over the past 5 years revenue at Cellularline grew +8.4 % a year. The price currently implies free-cash-flow growth of -11.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cellularline (CELL) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Cellularline (-11.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cellularline (CELL)?
The free-cash-flow yield on the price is 24.47 %: that much free cash flow Cellularline produces per unit of market value. When it exceeds the discount rate of our models (13.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cellularline (CELL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cellularline it is €6.77 per share (as of Nov 10, 2026), against a price of €2.70. It is the blended result of 11 valuation models in 4 families (DCF Models, Multiples, Asset-Based, Growth DCF).
Is Cellularline stock overvalued or undervalued in 2026?
As of Nov 10, 2026, CELL trades below its calculated fair value: price €2.70, fair value €6.77, a gap of about +151% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CELL?
No. The price is what the market pays today (€2.70); the fair value is what the company's own numbers justify (€6.77). For Cellularline the two are €4.07 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cellularline worth?
The market values Cellularline at about €56.1M (market capitalisation, as of Nov 10, 2026). Per share that is €2.70; our models calculate a fair value of €6.77 per share.
What do the bullish and bearish scenarios say about CELL?
Our models span a range for Cellularline: cautious scenario €4.64, base €6.77, optimistic €9.11 per share (as of Nov 10, 2026, price €2.70). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cellularline (CELL)?
Balance-sheet figures for Cellularline (as of Nov 10, 2026): return on equity −30.8%, debt of 0.15 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is CELL from its 52-week high?
Cellularline trades at €2.70, about 4% below its 52-week high of €2.81 and 33% above the low of €2.03 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of €6.77 is for.
Which stocks are comparable to Cellularline?
From the same area (Technology) we also value Samsung Electronics Co, Sony Group, Xiaomi Corporation, LG Electronics Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cellularline stock attractive at the current price?
The data as of Nov 10, 2026: price €2.70, calculated fair value €6.77 (+151%), Quality Score 54/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CELL calculated?
We run Cellularline through 11 models from 4 families: DCF Models, Multiples, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of €6.77 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. Cellularline currently trades 60% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cellularline (CELL)?
The closing price on Nov 9, 2026 was €2.70. Our model-based fair value is €6.77, about +151% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cellularline right now?
The price is below even our cautious bear case (€4.64). The market is more pessimistic than our downside scenario. Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (€4.64 to €9.11) leaves room in how you read the outcome.
Where does the earnings growth of Cellularline (CELL) come from?
Earnings per share at Cellularline grew −19.6 % a year from 2014 to 2025. Broken into its drivers: revenue per share −8.9 %, EBIT margin −16.1 %, tax rate +4.7 %, residual (interest, one-offs) +0.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Cellularline

How large is the market capitalisation of Cellularline (CELL)?
The market capitalisation of Cellularline is €56.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cellularline (CELL)?
The price-to-sales ratio of Cellularline is 0.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cellularline (CELL)?
Earnings per share at Cellularline are €−1.65. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cellularline (CELL)?
The dividend yield of Cellularline is 4.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cellularline (CELL)?
The net margin of Cellularline is −22.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cellularline (CELL)?
The return on equity (ROE) of Cellularline is −30.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cellularline (CELL)?
On an EBIT basis the return on assets of Cellularline is −10.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cellularline (CELL)?
The operating margin of Cellularline is 1.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cellularline (CELL)?
Revenue at Cellularline is growing +0.1% versus a year earlier (3y avg +4.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cellularline (CELL)?
Earnings per share at Cellularline are growing −11.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Cellularline (CELL) carry?
The net debt of Cellularline is €7.8M (fiscal year 2025, ≈ 0.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Cellularline in the live analysis

One click puts Cellularline on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.